Mednet Logo
HomeRadiation OncologyQuestion

How would you treat a BRAF WT metastatic melanoma patient with leptomeningeal disease in the frontline setting?

1
2 Answers
Mednet Member
Mednet Member
Medical Oncology · The Ohio State University Comprehensive Cancer Center / James Cancer Hospital and Solove Research Institute

LMD from melanoma carries a dismal prognosis (weeks to a few months of survival), depending on how symptomatic the patient is from the increased intracranial pressure. Please refer to a case report I published a while ago with Dr. Ahmad Tarhini from Moffitt Cancer Institute for a discussion of this ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

Register or Sign In to see full answer

How would you treat a BRAF WT metastatic melanoma patient with leptomeningeal disease in the frontline setting? | Mednet